Review article · 31 Oct 2020
EditorialPublished 2012
Clinical Trials Regulations in India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hitt Sharma and Sameer Parekh PDF Share this article
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference proceeding · 2020
India’s Clinical Trial Regulatory Changes, Indian Researchers’ Awareness of Recently Changed Regulations, and the Impact of the New Drugs and Clinical Trial Rules
Opinion · 29 Jul 2025
Evolving Clinical Trials: Regulation, Technology, Challenges
Article · 2 Sep 2024
Ethical Implications of Drug Regulation in Clinical Trials
Conference abstract · 2021
Reporting of adverse drug reactions and the Clinical Trials Regulation (Regulation (EU) No 536/2014): What will change?
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hitt Sharma”
- BylineArticles whose byline prints “Sameer Parekh”

